Jeremy Stackawitz

Jeremy Stackawitz is the CEO of Senzo, and has over 25 years of healthcare industry experience and 15 years of diagnostics experience. Before joining Senzo, from 2009-2021 Mr. Stackawitz held roles of CCO, President, and CEO at Quotient (QTNT), helping lead the company from start-up to IPO. From 2007 to 2009, Mr. Stackawitz was Worldwide Commercial Director at Ortho Clinical Diagnostics, and from 2004 to 2007 a Director at Therakos and Ortho Biotech, all Johnson & Johnson companies. Mr. Stackawitz also held consulting positions at Monitor and McKinsey & Company, and received a B.A. in Chemistry from Dartmouth College and a M.B.A. from Wharton, University of Pennsylvania.